| |
|
|
|
Corbus Pharmaceuticals Holdings Inc.  
|
|
8.66 -0.29 (-0.03%) |
02-19 15:40 |
|
Open: |
8.93 |
Pre close: |
8.95 |
Target:
|
10.64
|
|
High: |
8.93 |
Low: |
8.565 |
Resistance:
|
9.11
10.64
|
|
Volume: |
971,070 |
Market Cap: |
542M |
Support:
|
7.56
6.60
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.52
 |
MACD |
MACD(12,26):
|
0.38 |
|
MA(20): |
7.68 |
Signal(12,26,9): |
0.27 |
|
MA(100): |
6.99 |
Stochastic Oscillator |
%K(14,3):
|
80.65 |
|
MA(250): |
6.34 |
%D(3): |
79.82  |
|
Average Volume(K) |
3-Month: |
98315
|
52-Week |
High:
|
9.11 |
|
10-Days: |
158852 |
Low: |
4.50 |
|
RSI |
RSI(14):
|
61.36 |
Change(%): |
12.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.880 |
Return on Equity (ttm) |
-131.7 |
Shares Out. (M) |
57.25 |
|
EPS Est. Current Year |
-0.640 |
Return on Assets (ttm) |
-98.9 |
Shares Float (M) |
55.14 |
|
EPS Est. Next Year |
-0.680 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
37.0 |
% Held by Institutions |
58.10 |
|
Forward EPS |
-1.060 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
11.440 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.76 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.12 |
P/S |
10836719616.00 |
|
Operating Margin |
-1727.78 |
Levered Free Cash Flow
(M) |
-17.17 |
P/CF |
-19.71 |
|
|
|
|
|
|
